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INTRODUCTION
We have recently reported (3) that cytochalasin
B, which disrupts microfilaments, and colchicine,
which disrupts microtubules, interfered with the
release of a-amylase from rat parotid tissue slices.
Our observations on the effect of cytochalasin B on
a-amylase release have been confirmed by Rifkin
et al. (14). Inhibitory actions of cytochalasin B or
colchicine in several other systems have also been
reported (5, 11, 18, 19, 22) .
In contrast to the inhibitory action of either
cytochalasin B or colchicine, these agents have also
been shown to exert a stimulatory action in some
systems. For example, Orci et al. (12) have shown
that cytochalasin B enhanced the effect of glucose
on insulin release from isolated pancreatic islets
over the release observed with glucose alone . Simi-
larly, Temple et al. (18) have observed that colchi-
cine enhanced steroid production by an adrenal
tumor cell line.
Although the varied effects of cytochalasin B
and colchicine might be a function of the system
under study, they might also be a function of the
compound, or the concentration of the compound
used to alter the rate of a given process. In this
paper we report the results from a study of this
latter possibility.
MATERIALS AND METHODS
Parotid glands from a minimum of two female
Sprague-Dawley rats, 8-10 wk old, were obtained
and prepared at 37°C according to the procedure of
Babad et al. (1). Slices were incubated in stoppered,
1-oz plastic bottles with a total volume of 2.0 ml of
Krebs-Ringer bicarbonate buffer and 95% 02-5%
CO2 as the gas phase. The length of the incubation
periods is described in the legend to Table I . Cyto-
chalasin B was dissolved in dimethylsulfoxide (DM-
SO). When we used light-sensitive compounds the
studies were carried out in plastic bottles covered
with foil. At the end of the incubation periods the
tissue slices were separated from the buffer by filtering
through nylon gauze fitted over the tops of the plastic
bottles. Tissue slices were homogenized in 0.02 M
potassium phosphate-6.7 mM NaCI, pH 6.9. The
a-amylase of the tissue homogenates and incubation
buffer was assayed by the procedure of Bernfeld (2) .
All secretion data are listed as the percent of the
total a-amylase released into the incubation buffer .
All data are expressed as the average with the indi-
cated range from individual paired experiments
which have been repeated at least three times.
Colchicine was obtained from the Sigma Chemical
Co., St. Louis, Mo. Cytochalasin B was purchased
from Gallard-Schlesinger Chemical Mfg . Corp.,
Carle Place, N. Y. and Nß,02'-dibutyryl adenosine
3',5'-cyclic monophosphate (db-c-AMP) was ob-
tained from Schwarz/Mann Div., Becton, Dickinson
& Co., Orangeburg, N. Y. Colcemid was a gift from
the Geigy Pharmaceuticals, Div. Ciba-Geigy Cor-
poration, Ardsley, N. Y. Sprague-Dawley rats were
obtained from the Charles River Breeding Labora-
tories, Inc., Wilmington, Mass. DMSO was a product
of MC&B Manufacturing Chemists, Norwood,
Ohio.
RESULTS
Fig. 1 shows that cytochalasin B (52 µM) exerted
an effect on the release of a-amylase that was de-
pendent on the concentration of db-c-AMP. At
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1 .0 mM db-c-AMP, cytochalasin B reduced the
amount of a-amylase released by one-half. How-
ever, cytochalasin B was without effect at 0 .5 mM
db-c-AMP even though this concentration of db-c-
AMP alone stimulated a-amylase release. At
lower concentrations of db-c-AMP, which had
little or no effect on a-amylase release, cytochala-
sin B enhanced a-amylase release. Thus, depend-
ing on the concentration of db-c-AMP, cytochala-
sin B inhibited, was without apparent effect, or po-
tentiated the release of a-amylase.
We also obtained results similar to those above
with agents that disrupt the structural integrity of
the microtubule system. From Fig. 2 it can be seen
that colchicine potentiated a-amylase release at
0.1 and 0.5 mM db-c-AMP, but was without
effect at higher db-c-AMP concentrations in con-
trast to the results presented in Fig. 1 for cyto-
chalasin B.
Since the effects of cytochalasin B could repre-
sent some type of irreversible cytotoxic effect, we
conducted studies on the reversibility of the effect
of cytochalasin B as shown in Table I . Although
both the synergistic and inhibitory effects of cyto-
chalasin B were reversible, this does not establish
that these effects were the result of an interaction
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FiGuRE I The effect of cytochalasin B on the stimulation of a-amylase release by various concentrations
of db-c-AMP. Tissue slices from three rats were incubated for 1 h in the presence (triangles) or absence
(circles) of cytochalasin B (cyto. B), after which time db-c-AMP was added for an additional 30 min.
.0
of cytochalasin B with the microfilaments. It does,
however, rule out enhanced release of a-amylase
as a result of a permanent cytoxic effect . In addi-
tion, if cytochalasin B enhanced a-amylase release
at low db-c-AMP concentrations by a cytotoxic
mechanism, cytochalasin B alone should elevate
basal a-amylase release by a corresponding
amount; but it does not.
Kletzien et al. have shown that cytochalasin B
is a potent antagonist of sugar transport (9) . In an
attempt to gain insight into this latter possibility,
we have conducted studies in the absence of glu-
cose and other oxidizable substrates and have ob-
tained the same effect of cytochalasin B given
above (not shown).
It is known that the release of a-amylase is
strictly dependent upon a continuing energy sup-
ply (1) . Although no information on the effect of
cytochalasin B on ATP levels in the parotid is
available, Warner and Perdue (20) reported that
cytochalasin B did not alter ATP levels in chick
fibroblasts.
DISCUSSION
This is the first report of an effect of either cyto-
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FIGURE 2 The effect of colchicine on the stimulation of a-amylase release by various concentrations of
db-c-AMP. Tissue slices from three rats were incubated for 4 h in the presence (triangles) or absence
(circles) of colchicine (colch.), after which time db-c-AMP was added for an additional 30 min .
concentration of the effector compound used to
alter the rate of the process under investigation .
It has been noted previously by others (13) that
db-c-AMP can reverse the changes in cell mor-
phology induced by either Colcemid or cytochala-
sin. Kirkland and Burton (8) have also noted that
cyclic AMP appeared to stabilize the microtubules
to dissociation induced by low temperatures.
Butcher and Perdue (4) have previously reported
that cytochalasin B did not inhibit the induction
of tyrosine aminotransferase by db-c-AMP while
cytochalasin B did inhibit the induction of tyrosine
aminotransferase in the same system by either in-
sulin or cortisol. Thus, the present findings along
with the others cited above give indirect evidence
for some type of interaction between cyclic AMP
and the microtubular and microfilament networks .
Such an interaction might involve protein phos-
phorylation by a cyclic AMP-dependent protein
kinase in a manner analogous to activation of
glycogen phosphorylase kinase (10). This hypothe-
sis gains support from the recent observations of
Goodman et al. (7) who noted that tubulin iso-
lated from bovine brain could serve as a substrate
for protein kinase. In this regard it is of interest that
Schramm et al. (16) have reported that secretory
granules incubated with cyclic AMP and a protein
kinase formed a significantly greater number of
pseudopodia than the control secretory granules .
It is possible that the formation of pseudopodia
represents a meVhanism involving phosphorylation
of a protein of either the microfilament or micro-
tubule protein. This would imply that the micro-
tubule and microfilament systems were present in
secretory granules as well as the cytoplasm of the
parotid acinar cell .
An additional factor that might influence the in-
teraction of cyclic AMP with the microtubular and
microfilament systems is calcium . It is known that
calcium is required for the normal functioning of a
number of secretory systems (15) including secre-
tion of a-amylase from the rat parotid gland (17) .
A direct effect of calcium on microtubule function
is also suggested by the observation that calcium
inhibits the in vitro assembly of microtubule sub-
units (21). It has also been observed that calcium
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Reversal of the Effect of Cytochalasin B on the Stimulation of a-Amylase Release by db-c-AMP
* Tissue slices from four rats were divided into two equal portions, each incubated
separately either in the presence or in the absence of 52 µM cytochalasin B for 1 h.
After this time the two lots of tissue slices were washed twice with 10 ml of Krebs-
Ringer bicarbonate buffer and then added to plastic bottles for the second incubation
period. Cytochalasin B was added for either the first or second time as indicated,
and after 1 h the appropriate concentrations of db-c-AMP were added. After an addi-
tional 30-min period the percent of a-amylase released was determined.
$ Average of duplicate incubations from one experiment with the indicated range .
concentration exerts an effect on the intracellular
macromolecular binding of colchicine (6) .
In order to account for the present findings it is
possible that the low concentrations of db-c-AMP
are sufficient to promote reassembly of the micro-
filament or microtubule subunits. The cytoplasmic
activity caused by subunit reassembly might cause
the movement of the secretory granules to the sur-
face of the cells where they fuse with the plasma
membrane and spill their contents into the lumen .
This assumes that a rate-determining step in a-
amylase release is transport of secretory granules to
the cell surface.
Thus a stabilizing effect of db-c-AMP on micro-
filament or microtubule structure could account
for the enhancement of a-amylase release at low
levels of db-c-AMP. As the concentration of db-c-
AMP is increased other factors, such as a possible
effect on intracellular calcium distribution, might
prevent the positive effects of db-c-AMP on micro-
filament or microtubule subunit reassembly, re-
sulting in inhibition of a-amylase release . Conse-
quently, the inhibitory effect of cytochalasin B on
the stimulation of a-amylase by high concentra-
tions of db-c-AMP (1.0 mM) in Fig . I may repre-




gation whereas the effect observed at low concen-
trations represents a disequilibrium in favor of sub-
unit assembly. The point of no inhibition of a-
amylase (Fig. 1) then would represent an equilib-
rium between these two opposing rates .
SUMMARY
The effect of cytochalasin B (52 MM) and colchi-
cine (100 µM) on the stimulation of a-amylase re-
lease by db-c-AMP from rat parotid tissue slices
was a function of db-c-AMP concentration . Cyto-
chalasin B inhibited a-amylase, but colchicine was
not inhibitory . At submaximal concentrations of
db-c-AMP, neither cytochalasin B nor colchicine
inhibited a-amylase release. In the presence of
concentrations of db-c-AMP that alone had little
or no effect on a-amylase release, cytochalasin B
and colchicine enhanced the release of a-amylase
above that observed with db-c-AMP alone .
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Cytochalasin B 52 µM None 4 .8 f 1 . 7$
Al c-AMP 025 -7,4 - . . . 96 t 13
1 .0 mM 29 .8 t 2 .1
11 Cyto. B 52 µM 6 .2 t 0 .3
11 + db-c-AMP 0 .25 MM 15 .3 f 2 .9
11 1 .0 mm 17 .5 f 0 .1
None None 5 .4 f 0 .9
db-c-AMP 0 .25 mM 8 .4 f 0 .5
1 .0 mm 33 .1 f 1 .6
Cyto. B 52 µM 5 .9 f. 1 .2
+ db-c-AMP 0.25 mM 16 .8 f 0 .9
1 .0 mM 17 .3 t 1 .0REFERENCES
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